Medicine & Life Sciences
Shiga Toxin
100%
Hemolytic-Uremic Syndrome
74%
Complement Activation
52%
Blood Platelets
45%
Enterohemorrhagic Escherichia coli
36%
Atypical Hemolytic Uremic Syndrome
32%
Blood Cells
32%
Extracellular Vesicles
32%
Kinins
31%
Endothelial Cells
25%
Vasculitis
25%
Inflammation
24%
Platelet Activation
24%
Thromboplastin
23%
Kidney
21%
Leukocytes
20%
Shiga-Toxigenic Escherichia coli
20%
Complement Factor H
18%
Hemolysis
18%
Erythrocytes
17%
Virulence Factors
15%
Thrombotic Microangiopathies
15%
Clusterin
14%
Complement C3-C5 Convertases
14%
Mutation
13%
Thrombosis
13%
Kallikrein-Kinin System
13%
Flow Cytometry
12%
Exosomes
12%
Bacterial Toxins
12%
Neutrophils
12%
Purinergic Receptors
12%
Thrombotic Thrombocytopenic Purpura
11%
Lipopolysaccharides
11%
Escherichia coli Infections
11%
Mesangial Cells
11%
4,4,',4'',4'''-(carbonylbis(imino-5,1,3-benzenetriylbis(carbonylimino)))tetrakis(benzene-1,3-disulfonate)
10%
Complement Membrane Attack Complex
10%
Galactose
10%
Immunoglobulin A
9%
Serum
9%
Monocytes
9%
HeLa Cells
9%
globotriaosylceramide
7%
Carrier Proteins
7%
Edetic Acid
7%
Adenosine Triphosphate
7%
Suramin
7%
Interleukin-6
7%
Perfusion
7%
Agriculture & Biology
enterohemorrhagic Escherichia coli
15%
bacterial toxins
13%
hemolytic uremic syndrome
13%
Shiga toxin
13%
blood cells
12%
pathogenesis
8%
colitis
6%
virulence
6%
renal failure
5%